---
figid: PMC4302085__cjc-34-01-004-g001
figtitle: Networking of the PI3K/Akt/mTOR signaling pathway
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
pmcid: PMC4302085
filename: cjc-34-01-004-g001.jpg
figlink: /pmc/articles/PMC4302085/figure/cjc-34-01-004-g001/
number: F1
caption: PI3K/Akt/mTOR pathway is a central regulator of metabolism, survival, and
  proliferation in normal tissues and in cancers. Second only to the p53 pathway,
  this pathway is the one most frequently dysregulated in cancers. In addition to
  extrinsic activation from upstream growth factor receptors or via crosstalk from
  RAS, the pathway can be intrinsically and constitutively up-regulated due to activating
  mutations or amplifications in the positive effectors of the pathway (e.g., PIK3CA/PI3Kp110,
  Akt, and mTORC1) or via inactivating mutations or the loss of negative regulators
  of the pathway (e.g., PTEN, PIK3R1, TSC, and LKB1). In the setting of selective
  mTORC1 inhibition, mTORC2 activates Akt via Ser473 phosphorylation. PI3K, phosphatidylinositol
  3 kinase; mTOR, mammalian target of rapamycin; PIK3CA/PI3Kp110, phosphatidylinositol-4,5-biphosphate
  3-kinase, catalytic subunit alpha; mTORC1, mTOR complex-1; PTEN, phosphatase and
  tensin homolog; TSC, tuberous sclerosis complex; LKB1, liver kidney kinase B1; EGF,
  epidermal growth factor; IGF-1R, insulin growth factor 1 receptor; HER, v-erbB2
  avian eryhtorblastic leukemia viral oncogene homolog 2; EGFR, epidermal growth factor
  receptor; PIP2, phosphatidylinositol 4,5-bisphosphate; PDK1, pyruvate dehydrogenase
  kinase 1; MDM2, mouse double minute 2 homolog; NF-κB, nuclear factor-κB; CREB, cAMP
  response element-binding protein; GSK3, glycogen synthase kinase 3; 4EBP1, 4E binding
  protein 1.
papertitle: 'The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities
  and challenges.'
reftext: Bianca Cheaib, et al. Chin J Cancer. 2015 Jan;34(1):4-16.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9567838
figid_alias: PMC4302085__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Mus musculus
- Rattus norvegicus
redirect_from: /figures/PMC4302085__F1
ndex: a4217591-dee3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4302085__cjc-34-01-004-g001.html
  '@type': Dataset
  description: PI3K/Akt/mTOR pathway is a central regulator of metabolism, survival,
    and proliferation in normal tissues and in cancers. Second only to the p53 pathway,
    this pathway is the one most frequently dysregulated in cancers. In addition to
    extrinsic activation from upstream growth factor receptors or via crosstalk from
    RAS, the pathway can be intrinsically and constitutively up-regulated due to activating
    mutations or amplifications in the positive effectors of the pathway (e.g., PIK3CA/PI3Kp110,
    Akt, and mTORC1) or via inactivating mutations or the loss of negative regulators
    of the pathway (e.g., PTEN, PIK3R1, TSC, and LKB1). In the setting of selective
    mTORC1 inhibition, mTORC2 activates Akt via Ser473 phosphorylation. PI3K, phosphatidylinositol
    3 kinase; mTOR, mammalian target of rapamycin; PIK3CA/PI3Kp110, phosphatidylinositol-4,5-biphosphate
    3-kinase, catalytic subunit alpha; mTORC1, mTOR complex-1; PTEN, phosphatase and
    tensin homolog; TSC, tuberous sclerosis complex; LKB1, liver kidney kinase B1;
    EGF, epidermal growth factor; IGF-1R, insulin growth factor 1 receptor; HER, v-erbB2
    avian eryhtorblastic leukemia viral oncogene homolog 2; EGFR, epidermal growth
    factor receptor; PIP2, phosphatidylinositol 4,5-bisphosphate; PDK1, pyruvate dehydrogenase
    kinase 1; MDM2, mouse double minute 2 homolog; NF-κB, nuclear factor-κB; CREB,
    cAMP response element-binding protein; GSK3, glycogen synthase kinase 3; 4EBP1,
    4E binding protein 1.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - ERBB2
  - ERBB3
  - EGFR
  - IGF1R
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ARHGEF7
  - CBFA2T2
  - PPP1R13B
  - PPP1R12C
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - CUX1
  - SART3
  - STK11
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PDK1
  - PDPK1
  - EPHB2
  - MAPK1
  - MAPK3
  - PTEN
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - SLC12A3
  - TSC1
  - TESC
  - TSC2
  - MTOR
  - MDM2
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - CREB1
  - CREB3
  - CREB5
  - CREB3L1
  - CREB3L2
  - CREB3L3
  - CREB3L4
  - CREM
  - ATF1
  - ATF2
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - GSK3A
  - GSK3B
  - CDKN1A
  - TCEAL1
  - NSG1
  - H3P16
  - RHEB
  - RHEBP1
  - TP53
  - TP63
  - TP73
  - RPTOR
  - CCND1
  - RICTOR
  - EIF4EBP1
  - RPS6KB1
  - RPS6KB2
  - Egf
  - Erbb2
  - Erbb3
  - Egfr
  - Igf1r
  - Pik3r1
  - Ecm1
  - Ppp1r13b
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Pik3ca
  - Stk11
  - Mdk
  - Pdk1
  - Pdpk1
  - Ephb2
  - Mapk1
  - Pten
  - Akt1
  - Slc12a3
  - Tsc22d1
  - Mtor
  - Mdm2
  - Nfkb1
  - Creb1
  - Cdkn1b
  - Dctn6
  - Psmd9
  - Gsk3b
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Rheb
  - Trp53
  - Rptor
  - Ccnd1
  - Rictor
  - Eif4ebp1
  - Rps6kb1
  - Pik3cg
  - Ephb1
  - Prkaa2
  - Rela
  - Tmed7
  - Tp53
  - Th
  - Ser
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
